Testing effectiveness (Phase 2)Study completedNCT00660582
What this trial is testing
FLOX + Cetuximab (Erbitux®) for Patients With Metastatic Colorectal Cancer and Wild Type K-RAS Tumor
Who this might be right for
Metastatic Colorectal Cancer
Per Pfeiffer 152